Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis

We herein report the case of a 57-year-old woman presenting with a biopsy-proven tumefactive demyelinating lesion as her first clinical event. Subsequently, she displayed a relapsing-remitting course with recurrence of large demyelinating lesions exceeding 2 cm in diameter rather than the small ovoi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Intern Med
Egile Nagusiak: Nakamura, Masataka, Itani, Kumi, Miyake, Kousuke, Kunieda, Takenobu, Kaneko, Satoshi, Kusaka, Hirofumi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Japanese Society of Internal Medicine 2017
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5337470/
https://ncbi.nlm.nih.gov/pubmed/28090055
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak